Lacosamide Injection
Product Images NDC 70771-1682

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70771-1682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (2e8b7789 C673 4f02 B73b Bd465c71c7f5 01)

Label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) single-dose vial for intravenous use. Manufactured by Zydus Lifesciences Ltd., Vadodara, India. Includes dosage form, strength, route, and storage instructions. Features barcode and Zydus logo, with caution to keep out of reach of children.*

FDA Label Image

Carton Label (2e8b7789 C673 4f02 B73b Bd465c71c7f5 02)

Packaging label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Zydus Lifesciences Limited. The label indicates the product contains 10 single-dose vials of 20 mL each. It includes medication guide instructions, storage conditions, and a barcode. The label also notes the product is Rx only and not made with natural rubber latex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.